Patent intelligence · US
US 11155547
Compounds for and methods of treating diseases
Compounds for and methods of treating diseases
Patent details — US 11155547
- Jurisdiction
- US
- Status
- granted
- Grant date
- Oct 26, 2021
- Expiration
- Oct 21, 2041
- Applicant
- Alterity Therapeutics Limited
- Claims
- 18
- CPC classes
- A61P, A61P25/00, A61P25/16, A61P25/28
Quick answer
US 11155547 (Compounds for and methods of treating diseases) is held by Alterity Therapeutics Limited. Status: granted. Granted Oct 26, 2021. Expires Oct 21, 2041 (15 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Alterity Therapeutics Limited
- Grant date
- Expiration
- Claims
- 18
- CPC classes
- A61P, A61P25/00, A61P25/16, A61P25/28
More from Alterity Therapeutics Limited
Related pharmaceutical patents in our USPTO index.
Frequently asked questions
What is US patent 11155547?
US 11155547 (Compounds for and methods of treating diseases) is held by Alterity Therapeutics Limited. Status: granted. Granted Oct 26, 2021. Expires Oct 21, 2041 (15 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 11155547?
Alterity Therapeutics Limited is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 4 pharmaceutical patents for this assignee.
When does US 11155547 expire?
Our index shows an expiration date of Oct 21, 2041 (15 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.